Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jun;61(6):1241-1248.
doi: 10.1007/s00125-017-4518-6. Epub 2017 Dec 15.

Promises and pitfalls of electronic health record analysis

Affiliations
Review

Promises and pitfalls of electronic health record analysis

Ruth Farmer et al. Diabetologia. 2018 Jun.

Abstract

Routinely collected electronic health records (EHRs) are increasingly used for research. With their use comes the opportunity for large-scale, high-quality studies that can address questions not easily answered by randomised clinical trials or classical cohort studies involving bespoke data collection. However, the use of EHRs generates challenges in terms of ensuring methodological rigour, a potential problem when studying complex chronic diseases such as diabetes. This review describes the promises and potential of EHRs in the context of diabetes research and outlines key areas for caution with examples. We consider the difficulties in identifying and classifying diabetes patients, in distinguishing between prevalent and incident cases and in dealing with the complexities of diabetes progression and treatment. We also discuss the dangers of introducing time-related biases and describe the problems of inconsistent data recording, missing data and confounding. Throughout, we provide practical recommendations for good practice in conducting EHR studies and interpreting their results.

Keywords: Diabetes; Electronic health records; Epidemiology; Observational studies; Primary care; Review; Secondary care.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no duality of interest associated with this manuscript.

References

    1. Edwards L, Rooshenas L, Isaacs T. Inclusion of ethnic minorities in telehealth trials for type 2 diabetes: protocol for a systematic review examining prevalence and language issues. JMIR Res Protoc. 2016;5:e43. doi: 10.2196/resprot.5195. - DOI - PMC - PubMed
    1. Hussain-Gambles M, Atkin K, Leese B. Why ethnic minority groups are under-represented in clinical trials: a review of the literature. Health Soc Care Community. 2004;12:382–388. doi: 10.1111/j.1365-2524.2004.00507.x. - DOI - PubMed
    1. Zhang T, Tsang W, Wijeysundera HC, Ko DT. Reporting and representation of ethnic minorities in cardiovascular trials: a systematic review. Am Heart J. 2013;166:52–57. doi: 10.1016/j.ahj.2013.03.022. - DOI - PubMed
    1. Coloma PM, Schuemie MJ, Trifirò G, et al. Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project. Pharmacoepidemiol Drug Saf. 2011;20:1–11. doi: 10.1002/pds.2053. - DOI - PubMed
    1. Chamberlain JJ, Herman WH, Leal S, et al. Pharmacologic therapy for type 2 diabetes: synopsis of the 2017 American Diabetes Association standards of medical care in diabetes. Ann Intern Med. 2017;166:572–578. doi: 10.7326/M16-2937. - DOI - PubMed

Publication types

LinkOut - more resources